Home
About
FAQ
History (4)
Benefits and risks of early antilymphocyte rescue in simultaneous kidney-pancreas transplant recipients.
Progression of Electrocardiographic Abnormalities in Type 1 Diabetes During 16 Years of Follow-up: The Epidemiology of Diabetes Interventions and Complications (EDIC) Study.
Review of immunosuppressive usage in pancreas transplantation.
Thymoglobulin for induction or rejection therapy in pancreas allograft recipients: a single centre experience.
See All 4 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Review of immunosuppressive usage in pancreas transplantation.
Stratta RJ. Review of immunosuppressive usage in pancreas transplantation. Clin Transplant. 1999 Feb; 13(1 Pt 1):1-12.
View in:
PubMed
subject areas
Antilymphocyte Serum
Diabetes Mellitus, Type 1
Drug Therapy, Combination
Graft Survival
Humans
Immunosuppression
Immunosuppressive Agents
Kidney Transplantation
Pancreas Transplantation
authors with profiles
Robert J. Stratta MD